Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CD40L monoclonal antibody (5F3)

ADI-CSA-187-E 100 µg 319.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:CD154, gp39, TNFSF 5
Immunogen:Human CD154 transfected 300-19 cells (mouse pre-B cell line).
UniProt ID:P29965
Species reactivity:Human
Applications:Flow Cytometry
Recommended Dilutions/Conditions:Flow Cytometry (5-10µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~39kDa by Western blot.
Purity Detail:Protein A affinity purified.
Formulation:Lyophilized. In PBS, pH 7.2, containing 1% sucrose.
Shipping:Blue Ice Not Frozen
Long Term Storage:+4°C
Scientific Background:The cluster of differentiation (CD) proteins are a group of surface molecules so named for their use in the identification and classification of leukocytes. The structure and function of CD proteins varies greatly and includes a multitude of receptors involved in cell adhesion, signal transduction, and antigen recognition. For example, CD8 (cytotoxic) and CD8 (helper) are well established T-lymphocyte markers, and function as co-receptors for MHC-I and MHC-II, respectively.
CSA-187 FC
Flow cytometric analysis of CD154 expression on cells transfected with CD154 vector. Cells were stained with isotype control (open histogram) or CD40L (CD154) mAb (5F3) (shaded histogram).
Please mouse over
CSA-187 FC

Related Products

Goat anti-mouse IgG F(ab')2, polyclonal antibody (HRP conjugate) 

ELISA, IHC, WB | Print as PDF
ADI-SAB-100-J 1 ml 120.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
CD40L Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,